ECM Substrates Impact RNAi Localization at Adherens Junctions of Colon Epithelial Cells.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
23 Nov 2022
Historique:
received: 02 09 2022
revised: 08 11 2022
accepted: 18 11 2022
entrez: 11 12 2022
pubmed: 12 12 2022
medline: 15 12 2022
Statut: epublish

Résumé

The extracellular matrix (ECM) plays crucial roles in tissue homeostasis. Abnormalities in ECM composition are associated with pathological conditions, such as fibrosis and cancer. These ECM alterations are sensed by the epithelium and can influence its behavior through crosstalk with other mechanosensitive complexes, including the adherens junctions (AJs). We have previously shown that the AJs, through their component PLEKHA7, recruit the RNAi machinery to regulate miRNA levels and function. We have particularly shown that the junctional localization of RNAi components is critical for their function. Here, we investigated whether different ECM substrates can influence the junctional localization of RNAi complexes. To do this, we plated colon epithelial Caco2 cells on four key ECM substrates found in the colon under normal or pathogenic conditions, namely laminin, fibronectin, collagen I, and collagen IV, and we examined the subcellular distribution of PLEKHA7, and of the key RNAi components AGO2 and DROSHA. Fibronectin and collagen I negatively impacted the junctional localization of PLEKHA7, AGO2, and DROSHA when compared to laminin. Furthermore, fibronectin, collagen I, and collagen IV disrupted interactions of AGO2 and DROSHA with their essential partners GW182 and DGCR8, respectively, both at AJs and throughout the cell. Combinations of all substrates with fibronectin also negatively impacted junctional localization of PLEKHA7 and AGO2. Additionally, collagen I triggered accumulation of DROSHA at tri-cellular junctions, while both collagen I and collagen IV resulted in DROSHA accumulation at basal areas of cell-cell contact. Altogether, fibronectin and collagens I and IV, which are elevated in the stroma of fibrotic and cancerous tissues, altered localization patterns and disrupted complex formation of PLEKHA7 and RNAi components. Combined with our prior studies showing that apical junctional localization of the PLEKHA7-RNAi complex is critical for regulating tumor-suppressing miRNAs, this work points to a yet unstudied mechanism that could contribute to epithelial cell transformation.

Identifiants

pubmed: 36497003
pii: cells11233740
doi: 10.3390/cells11233740
pmc: PMC9737857
pii:
doi:

Substances chimiques

Laminin 0
MicroRNAs 0
RNA-Binding Proteins 0
Collagen 9007-34-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIH HHS
ID : P20 GM130457
Pays : United States
Organisme : NIH HHS
ID : R21 CA246233
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK123704
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA246233
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM103499
Pays : United States
Organisme : NIH HHS
ID : P30 DK123704
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK124553
Pays : United States
Organisme : NIH HHS
ID : P20 GM103499-21S1
Pays : United States
Organisme : NIH HHS
ID : R01 DK124553
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM130457
Pays : United States
Organisme : Abney Foundation
ID : Graduate Fellowship Award, Hollings Cancer Center, MUSC

Références

Nat Cell Biol. 2015 Sep;17(9):1145-57
pubmed: 26302406
FEBS J. 2021 Dec;288(24):6850-6912
pubmed: 33605520
Adv Exp Med Biol. 2019;1165:81-100
pubmed: 31399962
Oncogene. 2011 Sep 1;30(35):3766-83
pubmed: 21478904
Front Med (Lausanne). 2021 Apr 16;8:610189
pubmed: 33937276
Trends Cancer. 2016 Jun;2(6):279-282
pubmed: 28741525
Eur J Surg. 1998 Jun;164(6):457-64
pubmed: 9696447
Gut. 2015 Mar;64(3):367-72
pubmed: 25416065
Nat Cell Biol. 2019 Mar;21(3):348-358
pubmed: 30742093
Int J Mol Sci. 2020 Apr 07;21(7):
pubmed: 32272708
Clin Cancer Res. 2014 Jul 15;20(14):3637-43
pubmed: 25028505
Circ Res. 2019 Jun 21;125(1):117-146
pubmed: 31219741
Curr Biol. 2020 Mar 23;30(6):R249-R251
pubmed: 32208143
Science. 2012 Mar 9;335(6073):1232-5
pubmed: 22323741
Adv Exp Med Biol. 2018;1077:389-414
pubmed: 30357700
Biochim Biophys Acta. 2014 Aug;1840(8):2386-95
pubmed: 24721714
J Histochem Cytochem. 2019 Sep;67(9):643-661
pubmed: 31116062
Front Mol Biosci. 2020 Jan 31;6:160
pubmed: 32118030
Exp Cell Res. 1996 Jun 15;225(2):301-5
pubmed: 8660918
J Cell Sci. 2020 Apr 21;133(8):
pubmed: 32317312
J Glaucoma. 2014 Oct-Nov;23(8 Suppl 1):S20-3
pubmed: 25275899
J Cell Biol. 2011 Mar 21;192(6):907-17
pubmed: 21422226
J Cell Sci. 2009 Apr 15;122(Pt 8):1059-69
pubmed: 19339545
Clin Cancer Res. 2016 May 15;22(10):2427-34
pubmed: 26673797
Int J Mol Sci. 2019 Oct 07;20(19):
pubmed: 31591367
Science. 2018 Mar 9;359(6380):1097-1098
pubmed: 29590026
Cells. 2020 Apr 03;9(4):
pubmed: 32260126
BMC Gastroenterol. 2014 Nov 18;14:189
pubmed: 25407511
Biochim Biophys Acta Rev Cancer. 2020 Apr;1873(2):188356
pubmed: 32147542
Exp Cell Res. 2017 Sep 1;358(1):78-85
pubmed: 28412244
Clin Exp Metastasis. 2019 Jun;36(3):171-198
pubmed: 30972526
Matrix Biol. 2017 Jan;57-58:1-11
pubmed: 28040522
J Biol Chem. 2013 Oct 11;288(41):29356-68
pubmed: 23990464
Mol Cell. 2010 May 14;38(3):323-32
pubmed: 20471939
Biochem Biophys Rep. 2019 May 14;18:100650
pubmed: 31193165
Polymers (Basel). 2021 Aug 09;13(16):
pubmed: 34451183
Front Med (Lausanne). 2014 Aug 25;1:24
pubmed: 25593900
Nat Commun. 2021 Dec 8;12(1):7145
pubmed: 34880255
Nat Rev Mol Cell Biol. 2014 Dec;15(12):786-801
pubmed: 25415508
Front Cell Dev Biol. 2021 Jan 12;8:621644
pubmed: 33511134
Mol Biol Cell. 2020 Aug 1;31(17):1823-1834
pubmed: 32730166
J Crohns Colitis. 2008 Dec;2(4):279-90
pubmed: 21172225
Curr Opin Cell Biol. 2018 Oct;54:80-88
pubmed: 29843079
Annu Rev Cell Dev Biol. 2010;26:397-419
pubmed: 20690820
J Exp Clin Cancer Res. 2021 Mar 17;40(1):102
pubmed: 33731188
J Transl Med. 2019 Sep 14;17(1):309
pubmed: 31521169
Trends Mol Med. 2021 Oct;27(10):1000-1013
pubmed: 34389240
Nat Rev Genet. 2010 Sep;11(9):597-610
pubmed: 20661255
Oncogene. 2018 Jul;37(28):3790-3805
pubmed: 29651051
Cardiovasc Res. 2021 May 25;117(6):1450-1488
pubmed: 33135058
J Cell Biol. 2017 Oct 2;216(10):3073-3085
pubmed: 28877994
Nature. 2020 Nov;587(7835):555-566
pubmed: 33239795
Front Cell Dev Biol. 2021 Sep 21;9:730176
pubmed: 34621747
J Exp Clin Cancer Res. 2019 Mar 6;38(1):115
pubmed: 30841909
Food Chem Toxicol. 2020 Sep;143:111556
pubmed: 32640349
Cells. 2021 Sep 16;10(9):
pubmed: 34572092
Adv Drug Deliv Rev. 2021 Mar;170:353-368
pubmed: 32961203
Dev Cell. 2018 Nov 19;47(4):453-463.e3
pubmed: 30458138
Nat Cell Biol. 2020 Sep;22(9):1103-1115
pubmed: 32839548
Curr Biol. 2008 Dec 9;18(23):R1080-2
pubmed: 19081036
Biochim Biophys Acta Mol Cell Res. 2017 Jul;1864(7):1183-1194
pubmed: 28322932
J Cell Biochem. 2019 Mar;120(3):2782-2790
pubmed: 30321449
J Cell Biol. 2018 May 7;217(5):1571-1587
pubmed: 29467174
Nat Rev Mol Cell Biol. 2010 Jul;11(7):502-14
pubmed: 20571587
Nat Commun. 2020 Oct 9;11(1):5120
pubmed: 33037194
Subcell Biochem. 2012;60:379-414
pubmed: 22674080
J Exp Clin Cancer Res. 2018 Jul 11;37(1):146
pubmed: 29996940
J Recept Signal Transduct Res. 2021 Aug;41(4):313-320
pubmed: 32900261
World J Gastroenterol. 2014 Aug 7;20(29):9872-81
pubmed: 25110418
Sci Signal. 2015 Mar 17;8(368):re3
pubmed: 25783160
Methods Enzymol. 2007;426:69-84
pubmed: 17697880
J Cancer. 2017 Feb 25;8(4):674-682
pubmed: 28367247
Cell. 2008 Nov 28;135(5):948-59
pubmed: 19041755
Nat Cell Biol. 2020 Jan;22(1):97-107
pubmed: 31907411
Cold Spring Harb Perspect Biol. 2009 Sep;1(3):a003053
pubmed: 20066110
Adv Exp Med Biol. 2019;1165:117-142
pubmed: 31399964
Science. 2020 Nov 27;370(6520):
pubmed: 33243859
Nat Rev Mol Cell Biol. 2014 Aug;15(8):509-24
pubmed: 25027649
BMC Med. 2008 Apr 28;6:11
pubmed: 18442412
Cell Cycle. 2016;15(4):498-505
pubmed: 26822694
J Cell Sci. 2010 Dec 15;123(Pt 24):4195-200
pubmed: 21123617
Mol Biol Cell. 2017 Jul 15;28(15):2023-2034
pubmed: 28705832
Oncotarget. 2018 Jan 19;9(13):11020-11045
pubmed: 29541394
Anat Rec (Hoboken). 2017 Aug;300(8):1371-1390
pubmed: 28187500
Biochim Biophys Acta. 2008 Mar;1778(3):660-9
pubmed: 17854762
Methods Enzymol. 2007;426:47-67
pubmed: 17697879
Integr Biol (Camb). 2018 Jun 18;10(6):342-355
pubmed: 29790537
Curr Biol. 2013 Apr 22;23(8):731-6
pubmed: 23562268
Cancers (Basel). 2022 Jul 13;14(14):
pubmed: 35884455
J Cell Biol. 2016 Apr 25;213(2):243-60
pubmed: 27114502
J Cell Physiol. 2017 May;232(5):967-975
pubmed: 27775168
Mol Biol Cell. 2017 Jul 7;28(14):1833-1846
pubmed: 28684609
Nat Rev Mol Cell Biol. 2019 Aug;20(8):457-473
pubmed: 31182865
Open Biol. 2020 Feb;10(2):190278
pubmed: 32070233
Semin Cancer Biol. 2020 May;62:192-200
pubmed: 31518697
Int J Mol Sci. 2019 Jun 05;20(11):
pubmed: 31195621

Auteurs

Amanda C Daulagala (AC)

Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29425, USA.

Antonis Kourtidis (A)

Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29425, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH